ANI Pharma Launches Carbamazepine ER Capsules in US
PRINCETON, N.J., April 13, 2026 ANI Pharmaceuticals, Inc. has announced the commercial launch of Carbamazepine Extended-Release Capsules (100 mg,...
Alzheimer’s Disease Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody NSCLC Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
PRINCETON, N.J., April 13, 2026 ANI Pharmaceuticals, Inc. has announced the commercial launch of Carbamazepine Extended-Release Capsules (100 mg,...
MUMBAI, India and NAPLES, Fla., April 7, 2026 Lupin Limited has received approval from the U.S. Food and Drug...
